[AsCNP_DDR] ポスター40（シンポジウム40）
Noteworthy drug discovery/research and development - Aiming for innovation -

[AsCNP-DDR-6] BPN14770, an allosteric inhibitor of Phosphodiesterase 4D (PDE4D) developed for the treatment of Fragile X syndrome and other brain disorders such as Alzheimer’s disease

^○Hiroko ONO¹, Chong ZHANG², Ying XU³, James M O’DONNELL^{2, 3}, Hidekuni YAMAKAWA¹, Naotaka HORIGUCHI¹, Toshiyuki ASAKI¹, Mark E GURNEY⁴ (1. Drug Discovery & Disease Research Laboratory, Shionogi & Co., Ltd., 2. Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, 3. Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, 4. Tetra Discovery Partners Inc.)